Matinas Biopharma Holdings I

Penny Stocks Biotech Stocks Healthcare Stocks

$0.59

+0.02 (+3.15%)

As of Feb 8, 2:33 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 4 57%

Sell 3 43%

Price Target

Analyst Price Target +6,566.1% upside

Low Target $22.47

Average Target $39.33

High Target $48.65

Current Price $0.59

Current
$0.59

Target
$39.33

$22.47 $39.33 avg $48.65

Scenario Analysis

Bear Case

$22.47

3,708.5%

Low target

Base Case

$39.33

+6,566.1%

Avg target

Bull Case

$48.65

+8,145.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$41.06

-98.6% from high

52-Week Low

$27.31

+-97.8% from low

Target vs 52W High

$39.33

-4.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%